Skip to content

Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance

Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06219577
Enrollment
70
Registered
2024-01-23
Start date
2024-01-18
Completion date
2024-04-22
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

Single site, prospective, double-masked, randomized-controlled, two-arm study of the dry eye symptoms as well as corneal and conjunctival staining in subjects using 2 different eyedrops. Subjects will be assessed at a screening visit, and 2 follow-up visits. Clinical evaluations will include patient questionnaire, tear-breakup time, and slit lamp exam.

Interventions

DRUGSystane Complete Multi-Dose PF

Eyedrop

DRUGWalgreen's Lubricant Balance

Eyedrop

Sponsors

Sengi
CollaboratorINDUSTRY
Scripps Poway Eyecare and Optometry
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. * Subjects who currently have mild to moderate symptoms of dry eye as defined by a screening SANDE score of 20-55 inclusive (equivalent to OSDI score of 12 -32).2 * Subjects between the ages of 18-65. * Subjects willing to comply with the prescribed regimen and schedule of eye drops. * Subjects willing to attend all study visits. * Subjects willing to discontinue any current artificial tear use 24 hours prior to the baseline study visit.

Exclusion criteria

If any of the following

Design outcomes

Primary

MeasureTime frameDescription
SANDE QuestionnaireChange from baseline to 2 weeksThe Symptom Assessment iN Dry Eye (SANDE) questionnaire. Subjects are asked to place an 'X' on the line to indicate both the frequency and severity of their dry eye symptoms. Each question is scored from 0 to 100. The scores for frequency and severity are used to calculate a total score, where Total Score = square.root\[Q1 \* Q2\]. Higher total score on the questionnaire indicates more frequent or severe dry eye symptoms.

Other

MeasureTime frameDescription
Corneal and Conjunctival StainingChange from baseline to 2 weeksBaseline corneal and conjunctival staining with sodium fluorescein and Wratten filter assessed OU using the Academy of Ophthalmology 5 quadrant scheme. Each quadrant will be graded (0-3) giving a total score (by summation) of 0-15 per eye. A higher score is a worse outcome.
Non-invasive Tear Breakup TimeChange from baseline to 2 weeks

Countries

United States

Participant flow

Participants by arm

ArmCount
Systane Complete Multi-Dose PF
Systane Complete Multi-Dose PF: Eyedrop
35
Walgreen's Lubricant Balance
Walgreen's Lubricant Balance: Eyedrop
35
Total70

Baseline characteristics

CharacteristicSystane Complete Multi-Dose PFWalgreen's Lubricant BalanceTotal
Age, Continuous41.8 years
STANDARD_DEVIATION 14.2
39.4 years
STANDARD_DEVIATION 15.1
40.8 years
STANDARD_DEVIATION 14.5
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
25 Participants18 Participants43 Participants
Sex: Female, Male
Male
10 Participants17 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 350 / 35
other
Total, other adverse events
0 / 350 / 35
serious
Total, serious adverse events
0 / 350 / 35

Outcome results

Primary

SANDE Questionnaire

The Symptom Assessment iN Dry Eye (SANDE) questionnaire. Subjects are asked to place an 'X' on the line to indicate both the frequency and severity of their dry eye symptoms. Each question is scored from 0 to 100. The scores for frequency and severity are used to calculate a total score, where Total Score = square.root\[Q1 \* Q2\]. Higher total score on the questionnaire indicates more frequent or severe dry eye symptoms.

Time frame: Change from baseline to 2 weeks

ArmMeasureValue (MEAN)Dispersion
Systane Complete Multi-Dose PFSANDE Questionnaire-7.2 scoreStandard Deviation 11.7
Walgreen's Lubricant BalanceSANDE Questionnaire-2.2 scoreStandard Deviation 6
Other Pre-specified

Corneal and Conjunctival Staining

Baseline corneal and conjunctival staining with sodium fluorescein and Wratten filter assessed OU using the Academy of Ophthalmology 5 quadrant scheme. Each quadrant will be graded (0-3) giving a total score (by summation) of 0-15 per eye. A higher score is a worse outcome.

Time frame: Change from baseline to 2 weeks

ArmMeasureValue (MEAN)Dispersion
Systane Complete Multi-Dose PFCorneal and Conjunctival Staining-2.8 scoreStandard Deviation 1.8
Walgreen's Lubricant BalanceCorneal and Conjunctival Staining-0.9 scoreStandard Deviation 1.5
Other Pre-specified

Non-invasive Tear Breakup Time

Time frame: Change from baseline to 2 weeks

ArmMeasureValue (MEAN)Dispersion
Systane Complete Multi-Dose PFNon-invasive Tear Breakup Time3.1 secondsStandard Deviation 2.9
Walgreen's Lubricant BalanceNon-invasive Tear Breakup Time2.2 secondsStandard Deviation 4.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026